Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
20 February 2013
Update on 2004 Background Paper (Written by Saloni Tanna)
Priority Medicines for Europe and the World "A Public Health Approach to Innovation"
The Health Systems in Transition (HiT) series consists of country-based reviews that provide a detailed description of a health system and
...
of reform and policy initiatives in progress or under development in a specific country.
more
This publication seeks to describe the best treatments and practices based on the scientific evidence available at the time
...
of writing as evaluated by the authors and may change as a result of new research. Readers need to apply this knowledge to patients in accordance with the guidelines and laws of their country of practice. Some medications may not be available in some countries and readers should consult the specific drug information since not all the unwanted effects of medications are mentioned.
more
The document is intended to facilitate the detection, evaluation and management of incident EVD cases in Germany. It primarily addresses public hea
...
lth service staff and health care workers in hospitals, outpatient clinics and emergency services in Germany. It is a work in progress, intended to evolve over time. Updated 14 August 2015
more
There is no secret to our procedure: the daily scanning of the literature helps us to stay afloat in th
...
e never-ending waves of new publications about SARS-CoV-2 and COVID-19. Many papers discussed in the Top 10 will eventually make it into subsequent editions of COVID Reference.
more
This summary covers the preventive approach to breast cancer control and includes prophylactic medications, prophylactic surgery and lifestyle modifications for breast cancer prevention. Health prof
...
essional training and individual risk assessments and counseling are also discussed.
more
The World Drug Report 2022 is aimed not only at fostering greater international cooperation to counter the impact of
...
the world drug problem on health, governance and security, but also, with its special insights, at assisting Member States in anticipating and address-ing threats from drug markets and mitigating their consequences.
more
In Climate Change 2014: Impacts, Adaptation, and Vulnerability. Part A: Global and Sectoral Aspects. Contribution of Working Group II to the Fifth Assessment Report
...
of the Intergovernmental Panel on Climate Change
more
PLOS ONE | https://doi.org/10.1371/journal.pone.0196380 May 15, 2018
Clinical management handbook
This publication provides guidance on reducing disability and premature deaths from coronary heart disease, cerebrovascular disease and peripheral vascular disease in people at high risk, who have not yet experienced a cardiovascular event.
Cancer, diabetes, heart disease and stroke, chronic respiratory disease
Therapeutics Information and Pharmacovigilance Centre | TIPC